SPP1 and neoplasm: To further investigate the mechanisms underlying IL-6-dependent suppression of Bev anti-angiogenic activity, we examined the effects of IL-6 on secretion of the angiogenic modulators VEGF, Ang1/2, and osteopontin by tumor and HUVEC.